If you’ve ever taken a proton pump inhibitor (PPI) for heartburn or acid reflux, you’re in good company. These acid-reducing medications are widely used and available over the counter. But here’s something you might not know: they can alter how your body absorbs...
How Precision in Data Collection Shapes Outcomes and Informs Risk Assessment in Human Abuse Liability Research What is a HAL Study? A Human Abuse Liability (HAL) study is a critical tool in the pharmaceutical industry, designed to assess the abuse potential of drugs...
Happy Pride Month, everyone! 🌈 At BioPharma Services, Pride Month is more than a rainbow logo or a single month of celebration. It’s a time to pause, reflect, and reaffirm something we deeply believe: every person who steps through our doors, whether as a trial...
Introduction to Institutional Review Boards (IRBs) An Institutional Review Board (IRB) is an independent committee that reviews, approves, and monitors biomedical research that involves human participants. The primary purpose of an Institutional Review Board is to...
In pharmacokinetic analysis during the drug development processes, a well-structured sampling schedule is essential for accurately assessing the absorption, distribution, metabolism, and excretion (ADME) properties of a drug. However, missing data points remain...
Rare diseases, often referred to as orphan diseases, affect a small percentage of the population. Despite their rarity, these conditions collectively impact millions of lives. In Canada, as in many other countries, the regulation and development of treatments for rare...
